Leukemia Patients Stay In Remission More Than Two Years With New T Cell Therapy
Leukemia patients who received infusions of their own T cells, after the cells had been genetically engineered to fight the
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓